WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 2 | 3 ||

, ...

-- [ 4 ] --

113. O'Keeffe, M. Preliminary evaluation of a lateral flow immunoassay device for screening urine samples for the presence of sulphamethazine / M. O'Keeffe, P.

Crabbe, M. Salden et al. // Journal of Immunological Methods. 2003. V.278.

P. 117126.

114. Parpia, Z. p24 antigen rapid test for diagnosis of acute pediatric HIV infection / Z.

Parpia, R. Elghanian, A. Nabatiyan et al. // JAIDS. 2010. V.55. P. 413419.

115. Peel, M. Measurement of tetanus antitoxin II. Toxin neutralization / M. Peel // Journal of Biological Standardization. 1980. V. 8. P. 191207.

116. Pickering, J. Comparison of a Multiplex Flow Cytometric Assay with Enzyme Linked Immunosorbent Assay for Quantitation of Antibodies to Tetanus, Diphtheria, and Haemophilus influenzae Type b / J. Pickering, T. Martins, Schroder M. et al. // Clinical and Diagnostic Laboratory Immunology. 2002. V.9. P. 872876.

117. Pietsch, M. Impfserologie zur Ergnzung von Impfungen / M. Pietsch // Der Allgemeinarzt. 1993. V.18.

118. Placido Sousa, C. The Action of Diphtheria Toxin on Tissue Cultures and its Neutralization by Antitoxin / Placido Sousa C., Evans D. // British Journal of Experimental Pathology. 1957. V. 38. P. 644649.

119. Plikaytis, B. Determination of parallelism and nonparallelism in bioassay dilution curves / B. Plikaytis, P. Holder, L. Pais et al. // Journal of Clinical Microbiology.

1994. V.32. P. 24412447.

120. Plotkin, S. Vaccines, 4th Edition / ed by. S. Plotkin, W. Orenstein Philadelphia:Sanders, 2004. 1696 p.

121. PosthumaTrumpie, G. Development of a competitive lateral flow immunoassay for progesterone: Influence of coating conjugates and buffer components / G.

PosthumaTrumpie, J. Korf, A. Amerongen // Analytical and Bioanalytical Chemistry. 2008. V.392. P. 12151223.

122. PosthumaTrumpie, G. // Amorphous Carbon Nanoparticles: a Versatile Label for Rapid Diagnostic (Immuno)Assays / G. PosthumaTrumpie, J. Wichers, M. Koets et al. // Analytical and Bioanalytical Chemistry. 2012. V. 402. P. 593600.

123. Queenan, A. PertactinNegative Variants of Bordetella pertussis in the United States / A. Queenan, P. Cassiday, A. Evangelista // New England Journal of Medicine. 2013. V.368. P. 583584.

124. Rayev, M. Carbonprotein covalent conjugates in noninstrumental immunodiagnostic systems / M. Rayev, K. Shmagel // Journal of Immunological Methods. 2008. V.336. P.915.

125. Robbins, J. Toward a new vaccine for pertussis / J. Robbins, R. Schneerson, J.

KublerKielb et al. // Proceedings of the National Academy of Sciences. 2014. V. 111. P. 32133216.

126. Saffar, M. Pertussis Resurgence in a Highly Vaccinated Population, Mazandaran, North of Iran: An Epidemiological Analysis / M. Saffar, G. Jafar, Gholamreza et al. // Indian Journal of Pediatrics. 2014. V. 81. P. 13321336.

127. Sajid, M. Designs, formats and applications of lateral flow assay: A literature review / M. Sajid, A. Kawde, M. Daud // Journal of Saudi Chemical Society. 2014.

128. Sako, W. Studies on pertussis immunization / W. Sako // Journal of Pediatrics. 1947. V.30. P. 2940.

129. Salk, J. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissueculture system / J. Salk, J. Youngner, E. Ward // American Journal of Epidemiology. 1954. V. 60. P. 214230.

130. Scheibel, I. Duration of Immunity to Diphtheria and Tetanus after Active Immunization / I. Scheibel, M. Bentzon, P. Christensen // Acta pathologica et microbiologica Scandinavica. 1966. V.67. P. 380.

131. Scheifele, D., Ochnio J. The Immunological Basis for Immunization Series:

Diphtheria / D. Scheifele, J. Ochnio. Geneva: WHO Document Production Services, 2009. 28 p.

132. Schrder, J. Knowledgebased approach to clinical decisionsupport system, with an application in tetanus serology / J. Schrder, W. Kuhlmann, C. Trendelenburg // Clinica Chimica Acta. 1993. V.222. P. 7983.

133. Sedgwick, A. Rapid quantitative microenzymelinked immunosorbent assay for tetanus antibodies / A. Sedgwick, M. Ballow, K. Sparks et al. // Journal of Clinical Microbiology. 1983. V.18. P. 104109.

134. Sesardic, D. Targeting of specific domains of diphtheria toxin by sitedirected antibodies / D. Sesardic, V. Khan, M. Corbel // Microbiology. 1992. V. 138. 10. P. 21972203.

135. Shahin, R. Characterization of the protective capacity and immunogenicity of the 69kD outer membrane protein of Bordetella pertussis / R. Shahin, M. Brennan, Z.

Li // The Journal of Experimental Medicine. 1990. V.171. P. 6373.

136. Simonsen, O. ELISA for the routine determination of antitoxic immunity to tetanus / O. Simonsen, M. Bentzon, I. Heron // Journal of Biological Standardization. 1986. V. 14. P. 231239.

137. Simonsen, O. Modification of the ELISA for the estimation of tetanus antitoxin in human sera / O. Simonsen, C. Schou, I. Heron // Journal of Biological Standardization. 1987. V.15. P. 14357.

138. Simonsen, O. Vaccination against tetanus and diphtheria. Evaluation of immunity in the Danish population, guidelines for revaccination, and the methods for control of vaccination programmes / O. Simonsen // Danish Medical Bulletin. 1989. V.36. P.2447.

139. Smits, G. Development of a BeadBased Multiplex Immunoassay for Simultaneous Quantitative Detection of IgG Serum Antibodies against Measles, Mumps, Rubella, and VaricellaZoster Virus / G. Smits, P. van Gageldonk, L.

Schouls et al. // Clinical and Vaccine Immunology: CVI. 2012. 19. P. 396 400.

140. Stevenson, L. Parallelism: Considerations for the development, validation and implementation of PK and biomarker ligandbinding assays / L. Stevenson, S.

Purushothama // Bioanalysis. 2014. V. 6. 2. P. 185198.

141. StifflerRosenberg, G. Measurement of human tetanus antitoxin by enzymelinked immunosorbent assay (ELISA) / G. StifflerRosenberg, H. Fey // Schweizerische medizinische Wochenschrift. 1977. V. 107. P. 11011104.

142. Storsaeter, J. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis / J. Storsaeter, H. Hallander, Gustafsson L. et al. // Vaccine. 1998. V. 16. P. 19071916.

143. Storsaeter, J. Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance / J. Storsaeter, P. Olin // Vaccine. 1992. V. 10. P. 142144.

144. SurezPantalen, C. Development of an immunochromatographic assay based on carbon nanoparticles for the determination of the phytoregulator forchlorfenuron / C. SurezPantalen, J. Wichers, A. AbadSomovilla et al. // Biosensors and Bioelectronics. 2013. V.42. P. 170176.

145. Syed, M. Pertussis: A reemerging and an underreported infectious disease / M.

Syed, N. Bana // Saudi Medical Journal. 2014. V. 35. P. 11811187.

146. Tate, J. Interferences in Immunoassay / J. Tate, G. Ward // The Clinical Biochemist Reviews. 2004. V. 25. 2. P. 105120.

147. Tighe, P. ELISA in the multiplex era: Potentials and pitfalls ELISA in the multiplex era: Potentials and pitfalls / P. Tighe, Ryder R., Todd I. et al. // Proteomics Clinical applications. 2015. V.9. P. 406422.

148. Trollfors, B. A PlaceboControlled Trial of a PertussisToxoid Vaccine / B.

Trollfors, J. Taranger, T. Lagergrd et al. // New England Journal of Medicine. 1995. V. 333. P. 10451050.

149. van Amerongen, A. Colloidal carbon particles as a new label for rapid immunochemical test methods: Quantitative computer image analysis of results / A. van Amerongen, J. Wichers, L. Berendsen et al. // Journal of Biotechnology. 1993. V.30. P.185195.

150. van Dam, J. Diagnosis of Schistosomiasis by Reagent Strip Test for Detection of Circulating Cathodic Antigen G / J. van Dam, J. Wichers, T. Falcao Ferreira et al.

// Journal of Clinical Microbiology. 2004. V.42. P. 54585461.

151. van Gageldonk, P. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus / P. van Gageldonk, F. van Schaijk, F. van der Klis et al. // Journal of Immunological Methods. 2008. V. 335. P. 7989.

152. Walory, J. Comparison of four serological methods for the detection of diphtheria antitoxin antibody / J. Walory, P. Grzesiowski, W. Hryniewicz // Journal of Immunological Methods. 2000. V. 245. 12. P. 5565

153. WeisglasKuperus, N. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children / N. Weisglas Kuperus, S. Patandin, G. Berbers et al. // Environmental Health Perspectives. 2000. V. 108. P. 1203.

154. WHO. Weekly epidemiological record [ ]. 2006. No20.

:

P.198208.

http://www.who.int/immunization/wer8120tetanus_May06_position_paper.pdf

155. Wild, D. The Immunoassay handbook / D. Wild, J. Rhys, C. Sheehan et al. Oxford: Elsevier, 2013. 1013 p.

156. Wills, G. Pgp3 Antibody EnzymeLinked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection / G. Wills, P. Horner, R. Reynolds et al. // Clinical and Vaccine Immunology: CVI. 2009. V. 16. 6. P. 835843.

157. Wilson, A. Development and Evaluation of a Blocking EnzymeLinked Immunosorbent Assay and Virus Neutralization Assay To Detect Antibodies to Viral Hemorrhagic Septicemia Virus. A. Wilson, T. Goldberg, S. Marcquenski et al // Clinical and Vaccine Immunology: CVI. 2014. V. 21. 3. P. 435 442.

158. Wilson, D. Fifthgeneration digital immunoassay for prostatespecific antigen by single molecule array technology / D. Wilson, W. Hanlon, G. Provuncher et al. // Clinical Chemistry. 2011. V.57. P. 17121721.

159. Xu, H. The selection of ELISA cutoff points for testing antibody to Newcastle disease by twograph receiver operating characteristic (TGROC) analysis / H. Xu, J. Lohr, M. Greiner // Journal of Immunological Methods. 1997. V. 208. 1.

P. 6164

160. Xu, Y. Seroprevalence of pertussis in China: Need to improve vaccination strategies. / Y. Xu, L.Wang, J. Xu et al. // Human Vaccines & Immunotherapeutics.

2014. V.10. P.192198.

161. Yang, H. Evaluation of Parallelism Test Methods Using ROC Analysis / H. Yang, L. Zhang // Statistics in Biopharmaceutical Research. 2012. V.4. P.162173.

162. Youden, W. Index for rating diagnostic tests / W. Youden // Cancer. 1950. V.

3. 1. P. 3235.

163. Zackrisson, G. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin / G.

Zackrisson, J. Taranger, B. Trollfors // The Journal of Pediatrics. 1990. V.116.

P.190194.

164. Zweig, M. Receiveroperating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine / M. Zweig, G. Campbell // Clinical Chemistry.

1993. V.39 P. 561577.



Pages:     | 1 |   ...   | 2 | 3 ||
 

:

. 14.02.02 : , , 20 ...

- - 06.01.05. : ...

(SORBUS L.) 03.02.01 : ..., ... .. 2014 .. 4 1. .. 8 ...

() TETRANYCHUS ATLANTICUS MGREGOR : 06.01.07 : ...

BRUCELLA ABORTUS 19 BA, FRANCISELLA TULARENSIS 15 , YERSINIA PESTIS EV 03.02.03 :...

BRUCELLA ABORTUS 19 BA, FRANCISELLA TULARENSIS 15 , YERSINIA PESTIS EV 03.02.03 :...

(03.02.08) () : ...







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .